[Remote] Sales Training Manager, Oncology at BillionToOne

Remote

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, DiagnosticsIndustries

Requirements

Highly motivated and results-oriented individual
Ability to develop market landscape, product knowledge, messaging, selling skills, and territory management expertise for new sales hires, existing Oncology Sales Specialists, and Senior Oncology Sales Specialists
Capability to identify training gaps and collaborate on solutions
Ensuring alignment of goals between field teams, management, and leadership
Dotted line oversight of Field Sales Trainers (FSTs) and coordinating consistent in-territory support for new hires
Hands-on experience with structured new hire onboarding, field travel, and coaching to support sales performance and professional growth
Works closely with the Director of Sales Training, Oncology
Ensures consistency of messaging across departments and supports management’s OKRs
Establishes accountability and drives performance for the sales team
Individual contributor role reporting directly to the Director of Sales Training, Oncology

Responsibilities

Partner with the Director of Training to design, implement, and deliver consistent, concise, and clear training materials and messaging to the sales team, including new hire training, bi-weekly oncology training topics, product launches, and national/regional sales meetings
Lead the onboarding process for new sales team members, ensuring they are equipped with the knowledge and skills to succeed from day one
Maintain and update training pathways and continuing education courses within ShowPad or other LMS to ensure alignment with the company’s sales strategy, product offerings, and market demands
Field rides and performance coaching for new hires and established sales members
Cross-functional collaboration with sales leadership, analytics, marketing, Client Services, and other departments as needed to ensure alignment of new training content
Manage logistics for in-person new hire training programs
Support the upkeep of the Sales Training ChatBot with accurate, timely information
Lead/co-lead workshops and training activities at regional and national meetings, as well as New Hire Training sessions, under the direction of the Director of Training
Schedule regular touchpoints with FSTs to roll out new messaging, provide product updates, gather feedback on training needs, and field input

Skills

Sales Training

Product Knowledge

Selling Skills

Territory Management

Onboarding

Coaching

Field Training

Oncology Sales

Market Landscape Analysis

Sales Performance

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free